Icon
+91 94997 68112
Login Register

ACCUNEB (nda020949)- (EQ 0.042% BASE,EQ 0.021% BASE)

ALBUTEROL SULFATE MYLAN SPECIALITY LP
EQ 0.042% BASE,EQ 0.021% BASE
Yes Yes
2021-Dec-28 Expired
None None
None No
AccuNeb is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease).
4 0 4
Total Other Developers 2
Drugs with Suitability No
EQ 0.042% BASE ** ** - 3 -
EQ 0.021% BASE ** ** - 2 1
NDA Sales Available Total Generic Sales Available
No 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ******* ** ***. *********** **** **** ****** *********, **** ********, ***** ******** (**) *****, ****** ****** (***) ***
****** ****** **** ***** ******* *********** **** ** ****, *-*** ** *-***, *-*** ** *-***, **** ** *-***/*/*/*, *-****, *-***, *-***, *-***, ***** ********** ****, ********, *** ******, ***** (***) ***
****** ******** **** *** ******** *********** *********** * ********** ******, ********, ***** ******** (**) *****, ****** ****** (***) ***
****** ********** ********** (******) ******* *********** **********, *** ******** ******, ****** ********** ****, ******, ******* ******, ***** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.